DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mw2pzz/investigation) has announced the addition of the "Investigation Report on China Meropenam Market, 2010-2019" report to their offering.
Meropenam, developed together by Sumitomo Pharmaceuticals Co., Ltd and Imperial Chemical Industries Ltd, belongs to the second generation of broad- spectrum carbapenem and the first carbapenem which can be used alone. In 2014, the sales value of meropenam in the global market reached top to USD 1413 million with year-on-year growth of 2.91%.
Meropenam is the carbapenem with the largest number of manufacturers and highest annual output in today's China. According to the statistics, there are about 25 manufacturers of meropenam (chemical enterprises included) in China.
The division of labor is clear-cut; for example, some are responsible for mother nucleus, some for branched chain intermediate and others for Active Pharmaceutical Ingredient (API) synthesis. Major manufacturers of meropenam preparations in China are as follows: Shenzhen Haibin Pharmaceutical Co., Ltd, Hisun-Pfizer Pharmaceuticals Co., Ltd, Haikou Pharmaceutical Factory Co., Ltd, Shijiazhuang Pharma. Group Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. The sales value of meropenam in Chinese market reached CNY 968 million in 2014 and the CAGR during the period of 2005-2014 reached top to 27.1%.
It is widely believed in the medical field that meropenam is one of the few broad-spectrum antibiotics that can treat various infectious diseases. Therefore, meropenam will remain the main antibiotic for clinical medicine around the world and its sales in China is expected to keep increasing in the next few years.
Key Topics Covered:
1 Related Concepts of Meropenam
2 Market Profile of Meropenam in China
3 Survey on Sales Status of Meropenam in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Meropenam in China, 2010-2014
5 Survey on Dosage Forms of Meropenam in China, 2010-2014
6 Reference Price of Meropenam in Chinese Hospitals in 2014
7 Major Manufacturers of Meropenam in the Chinese Market, 2010-2014
8 Market Outlook of Meropenam in China, 2015-2019
- Haikou Pharmaceutical Factory Co., Ltd
- Hisun-Pfizer Pharmaceuticals Co., Ltd
- Shenzhen Haibin Pharmaceutical Co., Ltd
- Shijiazhuang Pharma. Group Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd
- Sumitomo Pharmaceuticals Co., Ltd
For more information visit http://www.researchandmarkets.com/research/mw2pzz/investigation